These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33007591)

  • 1. Automatically accounting for physical activity in insulin dosing for type 1 diabetes.
    Ozaslan B; Patek SD; Fabris C; Breton MD
    Comput Methods Programs Biomed; 2020 Dec; 197():105757. PubMed ID: 33007591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution.
    Fabris C; Ozaslan B; Breton MD
    Sensors (Basel); 2019 Dec; 19(24):. PubMed ID: 31817678
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and Feasibility Evaluation of Step Count Informed Meal Boluses in Type 1 Diabetes: A Pilot Study.
    Ozaslan B; Brown SA; Pinnata J; Barnett CL; Carr K; Wakeman CA; Clancy-Oliveri M; Breton MD
    J Diabetes Sci Technol; 2022 May; 16(3):670-676. PubMed ID: 33794675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus.
    Dinglas C; Muscat J; Adams T; Peragallo-Dittko V; Vintzileos A; Heo HJ
    Am J Obstet Gynecol; 2018 Aug; 219(2):191.e1-191.e6. PubMed ID: 29750952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin therapy in children and adolescents with type 1 diabetes.
    Malik FS; Taplin CE
    Paediatr Drugs; 2014 Apr; 16(2):141-50. PubMed ID: 24458650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replay Simulations with Personalized Metabolic Model for Treatment Design and Evaluation in Type 1 Diabetes.
    Hughes J; Gautier T; Colmegna P; Fabris C; Breton MD
    J Diabetes Sci Technol; 2021 Nov; 15(6):1326-1336. PubMed ID: 33218280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
    El-Khatib FH; Russell SJ; Magyar KL; Sinha M; McKeon K; Nathan DM; Damiano ER
    J Clin Endocrinol Metab; 2014 May; 99(5):1701-11. PubMed ID: 24483160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-loop glucose control: Automatic IOB-based super-bolus feature for commercial insulin pumps.
    Rosales N; De Battista H; Vehí J; Garelli F
    Comput Methods Programs Biomed; 2018 Jun; 159():145-158. PubMed ID: 29650309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Personalized and Adaptive Insulin Bolus Calculator Based on Double Deep Q- Learning to Improve Type 1 Diabetes Management.
    Noaro G; Zhu T; Cappon G; Facchinetti A; Georgiou P
    IEEE J Biomed Health Inform; 2023 May; 27(5):2536-2544. PubMed ID: 37027579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes-An In Silico Proof-of-Concept.
    Cappon G; Facchinetti A; Sparacino G; Georgiou P; Herrero P
    Sensors (Basel); 2019 Jul; 19(14):. PubMed ID: 31323886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mealtime Insulin Dosing by Carbohydrate Counting in Hospitalized Cardiology Patients: A Retrospective Cohort Study.
    Thurber KM; Dierkhising RA; Reiland SA; Pearson KK; Smith SA; O'Meara JG
    Diabetes Technol Ther; 2016 Jan; 18(1):15-21. PubMed ID: 26230278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Daily Physical Activity as Measured by Commonly Available Wearables on Mealtime Glucose Control in Type 1 Diabetes.
    Ozaslan B; Patek SD; Breton MD
    Diabetes Technol Ther; 2020 Oct; 22(10):742-748. PubMed ID: 32105515
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 15. A Correction Insulin Bolus Delivery Strategy for Decision Support Systems in Type 1 Diabetes.
    Cappon G; Pighin E; Prendin F; Sparacino G; Facchinetti A
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1832-1835. PubMed ID: 34891643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision Support Systems for Insulin Treatment Adjustment in People with Type 1 Diabetes.
    Nimri R
    Pediatr Endocrinol Rev; 2020 Mar; 17(Suppl 1):170-182. PubMed ID: 32208561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the "Second Day" Exercise Effect on Glycemic Control, Insulin Requirements, and CHO Intake in Type 1 Diabetes Adults.
    Müller-Korbsch M; Frühwald L; Heer M; Fangmeyer-Binder M; Reinhart-Mikocki D; Fasching P
    J Diabetes Sci Technol; 2021 Jan; 15(1):127-133. PubMed ID: 31583900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.